SEGLUROMET®

Drug Information Related Patent

Hold Company

MERCK SHARP DOHME

Learn More

Dosage and Administration

TABLET;ORAL

Specification

2.5MG;500MG
2.5MG;1GM
7.5MG;500MG
7.5MG;1GM

Indication

SEGLUROMET® can be used as auxiliary diet and exercise, so as to improve glycemic control in adults with type 2 diabetes.

Use

Instructions for Use

API

ERTUGLIFLOZIN
METFORMIN HYDROCHLORIDE

API Structure

We Supply

ERTUGLIFLOZIN

Note:

null

METFORMIN HYDROCHLORIDE

Note:

CP/BP/EP/JP/USP
Facility GMP
Product GMP
ASMF/USMF/US-FDA/KFDA/WHO/CEP/KDMF

null

Note:

null

Drug Patent

Patent No	Expiration Date
8080580	2030/7/13
9308204	2030/10/21
9439902	2030/10/21

API Patent

Patent No	Expiration Date
8080580	2030/7/13
9308204	2030/10/21
9439902	2030/10/21

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION